IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

RP Management, LLC

Q4 2019 Holdings

Filed 2020-02-14 | 6 holdings | $9.7M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Cytokinetics Inc(CYTK)COM NEW23282W605$9.3M875,65695.5%
Epizyme Inc(EPZMEUR)COM29428V104$164.0K6,666,6671.7%
Biohaven Pharmactl Hldg Co L(BHVN)COMG11196105$114.9K2,111,1111.2%
Immunomedics Inc(IMMU)COM452907108$92.5K4,373,1781.0%
Epizyme IncCallCOM29428V904$61.5K2,500,0000.6%
Sunesis Pharmaceuticals IncCOM867328700$44129,5170.0%